Vault-13

WUXI BIOLOGICS CAYMAN INC USD0000025 144A REG S ISIN KYG9700

COM · CUSIP G97008109

1 institutional holders +0 vs Q1 2020
3,086,2033.1m shares reported held*
$56.5mreported value*
0 new 1 added 0 reduced 0 sold out net bought ≈ $16.5m (+900.5k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $18.30.

Trends to Q2 2020

Institutional holders

Managers reporting a position, each quarter

001Q4 19: 1Q1 20: 1Q2 20: 11Q4 19Q1 20Q2 20
Numbers
QuarterHolders
Q4 20191
Q1 20201
Q2 20201

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
101Q1 20: 1 bought or addedQ1 20: 0 cut or sold outQ1 20Q2 20: 1 bought or addedQ2 20: 0 cut or sold outQ2 20
Numbers
QuarterBought or addedCut or sold out
Q1 202010
Q2 202010

Biggest buyers

GILDER GAGNON HOWE & CO LLC Added +900,547+900.5k

Biggest sellers

None

Holders, Q2 2020

#ManagerLocationShares Value% of their portfolioChangeShares change
1 GILDER GAGNON HOWE & CO LLC 0.44% of their portfolio New York, NY 3,086,2033.1m $56.5m $56.5m 0.44% Added +900.5k +900,547